Completed
A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes
NCT04569994
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Novo Nordisk Investigational Site Mainz, Germany